Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 9, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for February 20, 2008 Subscribe to this News Feed      
 

WellStep, Metro Atlanta Office-Based, Confidential Treatment Program for Opioid Dependence (Utilizing Suboxone), Alcoholism, and Internet/Gambling Addiction Announces its Executive Solutions Program

WellStep, a metro Atlanta office-based, confidential treatment program for opioid dependence (utilizing Suboxone), alcoholism, and internet/gambling addiction announces its Executive Solutions program for high level business executives, professional athletes, celebrities and other public figures.

(PRWEB) February 20, 2008 -- WellStep, a metro Atlanta office-based, confidential treatment program for opioid dependence (utilizing Suboxone), alcoholism, and internet/gambling addiction announces its Executive Solutions program designed for business executives, professional athletes, celebrities and other public figures.

WellStep is located in a private, comfortable medical office center in Alpharetta, Georgia, an upscale suburb just north of Atlanta.

Executive Solutions is designed to give an additional level of privacy to executives, professional athletes, celebrities, and other high profile individuals who do not want their treatment to become public knowledge.

Unique privacy protections of the program include direct appointment scheduling with the medical director, after-hours and weekend services, and one-on-one counseling instead of group therapy.

WellStep can assist out-of-town patients in finding convenient hotel accommodations in the area.

WellStep offers Suboxone (buprenorphine) for selected patients who are dependent on painkiller medications such as Percocet, Vicodin and Oxycontin. For those struggling with alcoholism, Vivitrol (naltexone) and Campral (acamprosate) may be prescribed. An innovative, personalized treatment approach combining medical and behavioral therapies is utilized to help ensure long-term success.

Mark S. Banov, MD, MPH is Medical Director of WellStep. Dr. Banov received training in addiction medicine from the Harvard University School of Public Health. He graduated from Johns Hopkins University and the Medical University of South Carolina. Dr. Banov is certified by the American Board of Preventive Medicine and is a Fellow of the American Board of Preventive Medicine. He is on the medical staff of Gwinnett Hospital System.

Joseph Kirkpatrick, PhD and Susan Rosovsky, CCADC direct counseling services.

For more information or to schedule an appointment, please call 770-753-9898 and indicate that you are interested in the Executive Solutions program or visit our website, www.wellstepatlanta.com.

###

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/SGFsZi1Mb3ZlLU1hZ24tU3VtbS1aZXRhLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web



OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Mark Banov
Wellstep, LLC
770-753-9898
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright